January 29, 2013
Youngevity® Essential Life Sciences (www.youngevity.com, see their affiliate http://infowarsteam.com/Freedom2), a wholly-owned subsidiary of AL International, Inc. (OTC Pink: JCOF) (www.alintjcof.com), a fast growing, innovative, global direct marketer of healthy lifestyle and nutritional products and gourmet fortified coffee, announced today the exciting results of a series of clinical research studies performed by Clemson University – Institute of Nutraceutical Research (“INR”).
The INR is a national leader in nutritional research and one of the most highly regarded organizations in the field of phytonutrients, vitamins and minerals. The goals of the INR are to develop greater confidence in product quality, effectiveness, and enhance consumer demand for quality nutraceutical products.
[...] Youngevity® Clinical Research Study Highlights:
• Dietary supplement safety is the most highly regarded aspect of any of the Youngevity® various products and has become synonymous with the Youngevity® name and brand. Although Youngevity® only uses nutrients that are absolutely needed by the body and in forms that are highly bioavailable, Youngevity® felt it was important to show empirically the range and degree of safety through looking at (3) factors – Genotoxicity, Anti-Genotoxicity, and Anti-Mutagenicity. The results of the experiments showed that Beyond Tangy Tangerine® and Ultimate Classic® at various concentrations did not show any genotoxicity.
• When Beyond Tangy Tangerine® and Ultimate Classic® were administered to healthy human cell lines, they did not induce or create any inflammatory response in levels above and below the recommended dosage. Beyond Tangy Tangerine® and Ultimate Classic® showed inflammation protective properties and heightened the body’s protective responses to possible inflammation.
• When Beyond Tangy Tangerine® and Ultimate Classic® were administered to healthy human colon cells, there was no significant death of healthy human cells compared to cancerous colon cells. Ultimate Classic® killed 95% of cancerous colon cells, 65% of cancerous liver cells, 65% of cancerous stomach cells, and 30% of cancerous breast cells. Beyond Tangy Tangerine® killed 60% of cancerous colon cells, 65% of cancerous liver and stomach cells, and 30% of cancerous breast cells.
• Beyond Tangy Tangerine® and Ultimate Classic® both exhibited efficient inhibition on proliferation of cancerous cells at the recommended dosage levels. Both products showed there was inhibition of the growth of more cancerous cells, preventing further malignant multiplication and growth of unhealthy cells.
The Clemson University studies have provided Youngevity® greater confidence in their products, scientists, formulators, and manufacturing processes and helped to understand some of the pathways the Youngevity® products may be working through in order to provide these benefits.
AL International CEO, Steve Wallach, adds, “At Youngevity® we have always sought to provide high quality and safe products, these studies have added to the assurance we have in all of the Youngevity® products.”
Read the full press release here.
Last week, Pharmacist Ben Fuchs, host of the GCN Radio Network’s The Bright Side, spoke to Alex about the dangers of using anti-depressant and SSRI drugs.
To purchase Youngevity’s line of natural health products – and also help
support Infowars – visit
http://infowarsteam.com/Freedom2
No comments:
Post a Comment